MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, ZZ. Lu, L. Wei, LL. Wu, F. Yu (Guangzhou, China)

    Objective: The aim of this study is to explore the function and mechanism of RNA m6A modification in gut-derived inflammation of Parkinson's disease (PD). Background:…
  • 2023 International Congress

    Neurophysiological analysis of the posterior subthalamic area in a patient with Holmes’ tremor

    M. Wilken, I. Cruz Varela, F. Villamil, S. Castillo Torres, M. Merello (Buenos Aires, Argentina)

    Objective: To analyze the neuronal firing patterns in the posterior subthalamic area (PSA) in a Holmes’ tremor (HT) patient who underwent DBS implantation procedure. Background:…
  • 2023 International Congress

    CBS presenting rapidly progressive anterior operculum syndrome with suggested background pathology of 4-repeat tauopathy by tau PET: A case report

    K. Nakamura, Y. Kuroha, M. Hatakeyama, A. Kimura, Y. Nakamura, Y. Murakami, M. Watanabe, H. Igarashi, T. Takahashi, H. Shimada (Niigata city, Japan)

    Objective: Report of a case with suspected TDP-43 proteinopathy as the pathological background in the early stage of the disease, and a final diagnosis of…
  • 2023 International Congress

    An investigation of early changes in the brain due to mild cognitive impairment in Parkinson’s disease

    N. Saadat, E. Mazerolle, J. Gawryluk (Victoria, Canada)

    Objective: To identify baseline structural brain differences between individuals with Parkinson's disease (PD) who go on to develop mild cognitive impairment (PD-MCI) and those who…
  • 2023 International Congress

    Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

    S. Gorcenco, E. Kafantari, J. Wallenius, C. Karremo, E. Alinder, S. Dobloug, M. Landqvist Waldö, E. Englund, H. Ehrencrona, K. Wictorin, K. Karrman, A. Puschmann (Lund, Sweden)

    Objective: In this study, we aimed to examine clinically and genetically a patient series with ataxia from southern Sweden with known or unknown genetic causes.…
  • 2023 International Congress

    Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study

    D. Martins, A. Lees, H. Reichmann, J-F. Rocha (Coronado, Portugal)

    Objective: This study aims to evaluate changes in Parkinson’s disease (PD) progression scales in patients with PD and motor fluctuations (MF) treated with once-daily opicapone…
  • 2023 International Congress

    Beta is jumping the queue: Temporal overlap of beta desynchronization and synchronization during rapid movement changes

    L. Winkler, M. Butz, A. Sharma, J. Vesper, A. Schnitzler, P. Fischer, J. Hirschmann (Düsseldorf, Germany)

    Objective: Movement initiation and termination are often studied in isolation. Here we shed light on the neural processes underlying rapid changes of ongoing movements, where…
  • 2023 International Congress

    Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

    J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)

    Objective: To assess current practices for timing of physical therapy (PT) in Parkinson’s disease (PD). Background: Most persons with Parkinson disease (PD) face increasing mobility…
  • 2023 International Congress

    Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

    M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: We tested whether inter- and intra-individual differences in clinical severity are determined by cortical compensation, and not just by basal ganglia dysfunction. Background: Motor…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley